Gastrointestinal Therapeutics Global Market Report 2026

Description

Gastrointestinal therapeutics encompass a variety of drugs, biologics, and treatment options used to prevent, manage, or treat disorders of the gastrointestinal tract, including the esophagus, stomach, intestines, liver, pancreas, and gallbladder. These therapies address conditions such as acid reflux, ulcers, irritable bowel syndrome, Crohn's disease, and gastrointestinal cancers.

The primary product categories of gastrointestinal therapeutics include over-the-counter gastrointestinal therapeutics and prescription-based gastrointestinal therapeutics. Over-the-counter gastrointestinal therapeutics are non-prescription medications intended to relieve common digestive problems such as heartburn, indigestion, gas, constipation, and diarrhea. These therapies are delivered through different routes of administration, including oral, intravenous, and others. They are applied across various indications, including inflammatory bowel disease, gastroesophageal reflux disease, peptic ulcer disease, irritable bowel syndrome, and others. The products are distributed via several channels, such as hospital pharmacies, retail pharmacies, and online pharmacies, and are used by diverse end users including hospitals, clinics, ambulatory surgical centers, diagnostic laboratories, and others.

Tariffs have affected the gastrointestinal therapeutics market by increasing the cost of imported raw materials, active pharmaceutical ingredients, and biologics, especially for prescription-based therapeutics. Segments such as proton pump inhibitors, biologics, and aminosalicylates are most impacted, with regions like North America and Asia-Pacific facing higher import duties. While tariffs have led to increased production costs and price adjustments, they have also encouraged local manufacturing, innovation in drug formulations, and enhanced domestic supply chain resilience.

The gastrointestinal therapeutics market research report is one of a series of new reports from The Business Research Company that provides gastrointestinal therapeutics market statistics, including gastrointestinal therapeutics industry global market size, regional shares, competitors with a gastrointestinal therapeutics market share, detailed gastrointestinal therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the gastrointestinal therapeutics industry. This gastrointestinal therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The gastrointestinal therapeutics market size has grown strongly in recent years. It will grow from $42.3 billion in 2025 to $44.72 billion in 2026 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to limited availability of biologics and advanced gastrointestinal therapies, increasing incidence of acid reflux and ulcers, reliance on hospital and clinic-based treatment, growing awareness of digestive health, dominance of traditional otc antacids and laxatives.

The gastrointestinal therapeutics market size is expected to see strong growth in the next few years. It will grow to $55.21 billion in 2030 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to development of targeted biologics and immunotherapies, expansion of ambulatory surgical centers and diagnostic laboratories, rising adoption of oral and intravenous delivery systems, increasing online pharmacy penetration, innovation in probiotics and digestive enzyme formulations. Major trends in the forecast period include rising prevalence of gastrointestinal disorders, increased adoption of biologics and advanced therapies, expansion of over-the-counter therapeutics, growing focus on personalized gastrointestinal treatments, rising online and retail pharmacy distribution.

The increasing prevalence of inflammatory bowel diseases is anticipated to drive the growth of the gastrointestinal therapeutics market in the coming years. Inflammatory bowel disease (IBD) is a chronic disorder characterized by inflammation of the digestive tract, mainly encompassing Crohn's disease and ulcerative colitis. The rising incidence of inflammatory bowel diseases is attributed to genetic susceptibility, which leads to an abnormal immune response to gut microbes. Gastrointestinal therapeutics support the management and treatment of bowel diseases by targeting underlying inflammation, regulating digestive processes, and relieving associated symptoms to improve patient outcomes. For instance, in December 2023, according to the IBD Registry, a UK-based non-profit organization, more than 5,300 individuals with inflammatory bowel diseases (IBD) were registered in 2023, representing an increase of over 3,000 members compared to 2022. Therefore, the growing prevalence of inflammatory bowel diseases is contributing to the expansion of the gastrointestinal therapeutics market.

Key companies operating in the gastrointestinal therapeutics market are concentrating on the development of innovative therapies, such as sustained-release (SR) fixed-dose combination capsules, to enhance patient adherence and improve treatment efficacy. Sustained-release (SR) fixed-dose combination capsules are oral formulations designed to slowly release multiple active ingredients over time, ensuring stable drug levels and reducing dosing frequency. For example, in June 2024, Akums Drugs and Pharmaceuticals Limited, an India-based pharmaceutical preparation manufacturing company, introduced rabeprazole and levosulpiride SR capsules for the treatment of gastrointestinal disorders in India. This formulation combines rabeprazole, a proton pump inhibitor that reduces gastric acid secretion, with levosulpiride, a prokinetic agent that enhances gut motility. Together, these components provide effective relief from symptoms such as heartburn, acid reflux, bloating, and indigestion. This combination therapy is commonly prescribed for managing gastroesophageal reflux disease, peptic ulcers, and other related gastrointestinal (GI) conditions.

In April 2023, Merck & Co., Inc., a US-based pharmaceutical company, acquired Prometheus Biosciences, Inc. for $10.8 billion. Through this acquisition, Merck & Co., Inc. aimed to strengthen its immunology pipeline by advancing precision-based therapies for inflammatory conditions such as ulcerative colitis and Crohn's disease. Prometheus Biosciences, Inc. is a US-based biotechnology company focused on the development of precision therapeutics for immune-mediated diseases, particularly gastrointestinal disorders.

Major companies operating in the gastrointestinal therapeutics market are Abbott Laboratories, Novartis AG, Takeda Pharmaceutical Company Limited., Boehringer Ingelheim International GmbH, Otsuka Holdings Co. Ltd., Daiichi Sankyo Company Limited., Bausch Health Companies Inc, UCB S.A., Eisai Co. Ltd., Aurobindo Pharma Limited., Dr. Reddy's Laboratories Limited., Ironwood Pharmaceuticals Inc, Salix Pharmaceuticals Ltd., Ferring Pharmaceuticals A/S, Jubilant Pharma Limited., Sebela Pharmaceuticals Inc, Cosmo Pharmaceuticals N.V., Tillotts Pharma AG, Mitsubishi Tanabe Pharma Corporation

North America was the largest region in the gastrointestinal therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the gastrointestinal therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The gastrointestinal therapeutics market consists of sales of acid suppressants, antiemetic agents, antispasmodics, digestive enzymes, and prebiotics and probiotics. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gastrointestinal Therapeutics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses gastrointestinal therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gastrointestinal therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The gastrointestinal therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

Markets Covered:1) By Product: Over-The-Counter Gastrointestinal Therapeutics; Prescription-Based Gastrointestinal Therapeutics
2) By Route Of Administration: Oral; Intravenous; Other Routes Of Administration
3) By Application: Inflammatory Bowel Disease; Gastroesophageal Reflux Disease; Peptic Ulcer Disease; Irritable Bowel Syndrome; Other Applications
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
5) By End-User: Hospitals; Clinics; Ambulatory Surgical Centers; Diagnostic Laboratories; Other End-Users
Subsegments:
1) By Over-The-Counter Gastrointestinal Therapeutics: Antacids; Laxatives; Anti-Diarrheal Agents; Digestive Enzymes; Probiotics; H2-Receptor Antagonists; Simethicone Products
2) By Prescription-Based Gastrointestinal Therapeutics: Proton Pump Inhibitors; Antibiotics For H. pylori; Aminosalicylates; Biologics; Corticosteroids; Immunosuppressants; Antiemetics
Companies Mentioned: Abbott Laboratories; Novartis AG; Takeda Pharmaceutical Company Limited.; Boehringer Ingelheim International GmbH; Otsuka Holdings Co. Ltd.; Daiichi Sankyo Company Limited.; Bausch Health Companies Inc; UCB S.A.; Eisai Co. Ltd.; Aurobindo Pharma Limited.; Dr. Reddy's Laboratories Limited.; Ironwood Pharmaceuticals Inc; Salix Pharmaceuticals Ltd.; Ferring Pharmaceuticals A/S; Jubilant Pharma Limited.; Sebela Pharmaceuticals Inc; Cosmo Pharmaceuticals N.V.; Tillotts Pharma AG; Mitsubishi Tanabe Pharma Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Product Code: PH4MGTHE05_G26Q1

1. Executive Summary

1.1. Key Market Insights (2020-2035)
1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
1.3. Major Factors Driving the Market
1.4. Top Three Trends Shaping the Market

2. Gastrointestinal Therapeutics Market Characteristics

2.1. Market Definition & Scope
2.2. Market Segmentations
2.3. Overview of Key Products and Services
2.4. Global Gastrointestinal Therapeutics Market Attractiveness Scoring And Analysis
- 2.4.1. Overview of Market Attractiveness Framework
- 2.4.2. Quantitative Scoring Methodology
- 2.4.3. Factor-Wise Evaluation
Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation
2.4.5. Strategic Implications and Recommendations

3. Gastrointestinal Therapeutics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem
3.2. List Of Key Raw Materials, Resources & Suppliers
3.3. List Of Major Distributors and Channel Partners
3.4. List Of Major End Users

4. Global Gastrointestinal Therapeutics Market Trends And Strategies

4.1. Key Technologies & Future Trends
- 4.1.1 Biotechnology, Genomics & Precision Medicine
- 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
- 4.1.3 Industry 4.0 & Intelligent Manufacturing
- 4.1.4 Artificial Intelligence & Autonomous Intelligence
- 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
- 4.2.1 Rising Prevalence Of Gastrointestinal Disorders
- 4.2.2 Increased Adoption Of Biologics And Advanced Therapies
- 4.2.3 Expansion Of Over-The-Counter Therapeutics
- 4.2.4 Growing Focus On Personalized Gastrointestinal Treatments
- 4.2.5 Rising Online And Retail Pharmacy Distribution

5. Gastrointestinal Therapeutics Market Analysis Of End Use Industries

5.1 Hospitals
5.2 Clinics
5.3 Ambulatory Surgical Centers
5.4 Diagnostic Laboratories
5.5 Pharmacies

6. Gastrointestinal Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Gastrointestinal Therapeutics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Gastrointestinal Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Gastrointestinal Therapeutics Market Size, Comparisons And Growth Rate Analysis
7.3. Global Gastrointestinal Therapeutics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Gastrointestinal Therapeutics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Gastrointestinal Therapeutics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Gastrointestinal Therapeutics Market Segmentation

9.1. Global Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Over-The-Counter Gastrointestinal Therapeutics, Prescription-Based Gastrointestinal Therapeutics
9.2. Global Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Oral, Intravenous, Other Routes Of Administration
9.3. Global Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Inflammatory Bowel Disease, Gastroesophageal Reflux Disease, Peptic Ulcer Disease, Irritable Bowel Syndrome, Other Applications
9.4. Global Gastrointestinal Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
9.5. Global Gastrointestinal Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospitals, Clinics, Ambulatory Surgical Centers, Diagnostic Laboratories, Other End-Users
9.6. Global Gastrointestinal Therapeutics Market, Sub-Segmentation Of Over-The-Counter Gastrointestinal Therapeutics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Antacids, Laxatives, Anti-Diarrheal Agents, Digestive Enzymes, Probiotics, H2-Receptor Antagonists, Simethicone Products
9.7. Global Gastrointestinal Therapeutics Market, Sub-Segmentation Of Prescription-Based Gastrointestinal Therapeutics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Proton Pump Inhibitors, Antibiotics For H. pylori, Aminosalicylates, Biologics, Corticosteroids, Immunosuppressants, Antiemetics

10. Gastrointestinal Therapeutics Market Regional And Country Analysis

10.1. Global Gastrointestinal Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Gastrointestinal Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Gastrointestinal Therapeutics Market

11.1. Asia-Pacific Gastrointestinal Therapeutics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Gastrointestinal Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Gastrointestinal Therapeutics Market

12.1. China Gastrointestinal Therapeutics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Gastrointestinal Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Gastrointestinal Therapeutics Market

13.1. India Gastrointestinal Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Gastrointestinal Therapeutics Market

14.1. Japan Gastrointestinal Therapeutics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Gastrointestinal Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Gastrointestinal Therapeutics Market

15.1. Australia Gastrointestinal Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Gastrointestinal Therapeutics Market

16.1. Indonesia Gastrointestinal Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Gastrointestinal Therapeutics Market

17.1. South Korea Gastrointestinal Therapeutics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Gastrointestinal Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Gastrointestinal Therapeutics Market

18.1. Taiwan Gastrointestinal Therapeutics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Gastrointestinal Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Gastrointestinal Therapeutics Market

19.1. South East Asia Gastrointestinal Therapeutics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Gastrointestinal Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Gastrointestinal Therapeutics Market

20.1. Western Europe Gastrointestinal Therapeutics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Gastrointestinal Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Gastrointestinal Therapeutics Market

21.1. UK Gastrointestinal Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Gastrointestinal Therapeutics Market

22.1. Germany Gastrointestinal Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Gastrointestinal Therapeutics Market

23.1. France Gastrointestinal Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Gastrointestinal Therapeutics Market

24.1. Italy Gastrointestinal Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Gastrointestinal Therapeutics Market

25.1. Spain Gastrointestinal Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Gastrointestinal Therapeutics Market

26.1. Eastern Europe Gastrointestinal Therapeutics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Gastrointestinal Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Gastrointestinal Therapeutics Market

27.1. Russia Gastrointestinal Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Gastrointestinal Therapeutics Market

28.1. North America Gastrointestinal Therapeutics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Gastrointestinal Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Gastrointestinal Therapeutics Market

29.1. USA Gastrointestinal Therapeutics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Gastrointestinal Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Gastrointestinal Therapeutics Market

30.1. Canada Gastrointestinal Therapeutics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Gastrointestinal Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Gastrointestinal Therapeutics Market

31.1. South America Gastrointestinal Therapeutics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Gastrointestinal Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Gastrointestinal Therapeutics Market

32.1. Brazil Gastrointestinal Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Gastrointestinal Therapeutics Market

33.1. Middle East Gastrointestinal Therapeutics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Gastrointestinal Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Gastrointestinal Therapeutics Market

34.1. Africa Gastrointestinal Therapeutics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Gastrointestinal Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Gastrointestinal Therapeutics Market Regulatory and Investment Landscape

36. Gastrointestinal Therapeutics Market Competitive Landscape And Company Profiles

36.1. Gastrointestinal Therapeutics Market Competitive Landscape And Market Share 2024
- 36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Gastrointestinal Therapeutics Market - Company Scoring Matrix
- 36.2.1. Market Revenues
- 36.2.2. Product Innovation Score
- 36.2.3. Brand Recognition
36.3. Gastrointestinal Therapeutics Market Company Profiles
- 36.3.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 36.3.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 36.3.3. Takeda Pharmaceutical Company Limited. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.4. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis
- 36.3.5. Otsuka Holdings Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

37. Gastrointestinal Therapeutics Market Other Major And Innovative Companies

Daiichi Sankyo Company Limited., Bausch Health Companies Inc, UCB S.A., Eisai Co. Ltd., Aurobindo Pharma Limited., Dr. Reddy's Laboratories Limited., Ironwood Pharmaceuticals Inc, Salix Pharmaceuticals Ltd., Ferring Pharmaceuticals A/S, Jubilant Pharma Limited., Sebela Pharmaceuticals Inc, Cosmo Pharmaceuticals N.V., Tillotts Pharma AG, Mitsubishi Tanabe Pharma Corporation

38. Global Gastrointestinal Therapeutics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Gastrointestinal Therapeutics Market

40. Gastrointestinal Therapeutics Market High Potential Countries, Segments and Strategies

40.1 Gastrointestinal Therapeutics Market In 2030 - Countries Offering Most New Opportunities
40.2 Gastrointestinal Therapeutics Market In 2030 - Segments Offering Most New Opportunities
40.3 Gastrointestinal Therapeutics Market In 2030 - Growth Strategies
- 40.3.1 Market Trend Based Strategies
- 40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations
41.2. Currencies
41.3. Historic And Forecast Inflation Rates
41.4. Research Inquiries
41.5. The Business Research Company
41.6. Copyright And Disclaimer